NDC11 13107003234
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 13107-0032-34 | 13107-0032 |
| 13107-032-34 | 13107-032 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Mirtazapine | MIRTAZAPINE | Aurolife Pharma LLC | aa05d606-29fd-443e-802b-1d65584d6bb1 | 2025-09-10 | Boxed warning, Warnings, Adverse reactions | 13107-032-34 13107-032 13107003234 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.